首页> 外文期刊>Proteomics >A Proteomic approach for protein-profiling the oncogenic ras induced transformation (H-, K-, and N-Ras) in NIH/3T3 mouse embryonic fibroblasts.
【24h】

A Proteomic approach for protein-profiling the oncogenic ras induced transformation (H-, K-, and N-Ras) in NIH/3T3 mouse embryonic fibroblasts.

机译:一种蛋白质组学方法,对NIH / 3T3小鼠胚胎成纤维细胞中的致癌性ras诱导的转化(H-,K-和N-Ras)进行蛋白质分析。

获取原文
获取原文并翻译 | 示例
           

摘要

Point mutations in three kinds of Ras protein (H-, K-, and N-Ras) that specifically occur in codons 12, 13, and 61 facilitate virtually all of the malignant phenotype of the cancer cells, including cellular proliferation, transformation, invasion, and metastasis. In order to elucidate an understanding into the oncogenic ras networks by H-, K-, and N-Ras/G12V, we have established various oncogenic ras expressing NIH/3T3 mouse embryonic fibroblast clones using the tetracycline-induction system, which are expressing Ras/G12V proteins under the tight control of expression by an antibiotics, doxycycline. Here we provide a catalog of proteome profiles in total cell lysates derived from three oncogenic ras expressing NIH/3T3 cells and a good in vitro model system for dissecting the protein networks due to these oncogenic Ras proteins. In this biological context, we compared total proteome changes by the combined methods of 2-DE, quantitative image analysis, and MALDI-TOF MS analysis using the unique Tet-on inducible expression system. There were a large number of common targets for oncogenic ras, which were identified in all three cell lines and consisted of 204 proteins (61 in the pH range of 4-7, 63 in 4.5-5.5, and 80 in 5.5-6.7). Differentially regulated expression was further confirmed for some subsets of candidates by Western blot analysis using specific antibodies. Taken together, we implemented a 2-DE-based proteomics approach to the systematical analysis of the dysregulations in the cellular proteome of NIH/3T3 cells transformed by three kinds of oncogenic ras. Our results obtained and presented here show that the comparative analysis of proteome from oncogenic ras expressing cells has yielded interpretable data to elucidate the differential protein expression directly and/or indirectly, and contributed to evaluate the possibilities for physiological, and therapeutic targets. Further studies are in progress to elucidate the implications of these findings in the regulation of Ras induced transformation.
机译:三种Ras蛋白(H-,K-和N-Ras)中的点突变特别发生在密码子12、13和61中,实际上促进了癌细胞的所有恶性表型,包括细胞增殖,转化,侵袭和转移。为了阐明对H-,K-和N-Ras / G12V的致癌ras网络的理解,我们使用四环素诱导系统建立了表达Ras的NIH / 3T3小鼠胚胎成纤维细胞克隆,这些克隆表达Ras / G12V蛋白受到抗生素强力霉素的严格控制。在这里,我们提供了来自三种表达ras基因的NIH / 3T3细胞的总细胞裂解物中蛋白质组图谱的目录,以及用于剖析这些致癌Ras蛋白的蛋白质网络的良好体外模型系统。在这种生物学背景下,我们使用独特的Tet-on诱导表达系统,通过2-DE,定量图像分析和MALDI-TOF MS分析的组合方法比较了总蛋白质组的变化。在所有三种细胞系中都发现了许多致癌性ras的共同靶标,它们由204种蛋白质组成(pH在4-7范围内为61种,在4.5-5.5范围内为63种,在5.5-6.7范围内为80种)。通过使用特异性抗体的蛋白质印迹分析,进一步证实了某些候选子集的差异调节表达。综上所述,我们实施了一种基于2-DE的蛋白质组学方法,系统分析了由三种致癌性ras转化的NIH / 3T3细胞的细胞蛋白质组中的失调。我们在此处获得并呈现的结果表明,对来自致癌ras表达细胞的蛋白质组进行的比较分析已产生可解释的数据,可以直接和/或间接阐明差异蛋白的表达,并有助于评估生理和治疗靶标的可能性。进一步的研究正在进行中,以阐明这些发现在Ras诱导的转化调控中的意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号